Prof. Yufu Li 李玉富
Chief Physician, Professor
Department of Hematology, Henan Cancer Hospital, Zhengzhou
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Diagnosis and treatment of lymphoma, leukemia, and myeloma. Management of hematologic diseases and chemotherapy for common tumors, with specific expertise in subtypes of non-Hodgkin and Hodgkin lymphoma.
Dr. Li holds a medical doctorate and serves as Chief of the Hematology and Lymphoma Ward and Deputy Director of Hematology at Henan Cancer Hospital. A graduate supervisor at Zhengzhou University, Dr. Li participates in national and provincial research projects. The doctor has published over 50 papers and authored two books.
Professional roles
- Standing Committee Member, Lymphoma Professional Committee, China Anti-Cancer Association
- Standing Committee Member, Tumor Clinical Chemotherapy Professional Committee, China Anti-Cancer Association
- Standing Committee Member, Lymphatic and Hematologic Tumor Professional Committee, Chinese Society of Geriatric Oncology
- Chair, Lymphoma Alliance, Henan Life Care Association
Name order: in Chinese the family name comes first (Li Yufu). Papers usually list the name as Yufu Li or Li Y.
Selected publications
46 papers on PubMed matched by name and affiliation; 5 as first or senior author since 2016. Most recent first- or senior-author papers:
- Blood Adv, 2022 (senior author): Zanubrutinib monotherapy for relapsed or refractory non-germinal center diffuse large B-cell lymphoma. PubMed 34638136
- Bioengineered, 2021 (senior author): Transcription factor 3 (TCF3) combined with histone deacetylase 3 (HDAC3) down-regulates microRNA-101 to promote Burkitt lymphoma cell proliferation and inhibit apoptosis. PubMed 34658308
- Environ Toxicol, 2021 (senior author): CircKDM4C upregulates P53 by sponging hsa-let-7b-5p to induce ferroptosis in acute myeloid leukemia. PubMed 33733556
- Leuk Lymphoma, 2016 (senior author): Sequential DICE combined with l-asparaginase chemotherapy followed by involved field radiation in newly diagnosed, stage IE to IIE, nasal and extranodal NK/T-cell lymphoma. PubMed 26726970
- Zhonghua Xue Ye Xue Za Zhi, 2016 (first author): [Primary renal lymphoma with the initial symptom of nephrotic syndrome: a case report]. PubMed 27093986
- Oncol Lett, 2015 (senior author): Primary skeletal muscle diffuse large B cell lymphoma: A case report and review of the literature. PubMed 26622811
- Zhongguo Shi Yan Xue Ye Xue Za Zhi, 2014 (senior author): [Expression of TRAF-6,TAK1 and TGF-β mRNA in peripheral blood mononuclear cells of patients with diffuse large B cell lymphoma before and after chemotherapy]. PubMed 25338577
- Zhonghua Xue Ye Xue Za Zhi, 2014 (senior author): [A case of non-Hodgkin's lymphoma with lower limbs muscle localization]. PubMed 25152117
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion